Induction of tumor lymphangiogenesis by VEGF-C promotes breast cancer metastasis

Nature Medicine

Volumn 7, Issue 2, 2001, Pages 192-198

  Skobe, Mihaela ^a   Hawighorst, Thomas ^a   Jackson, David G ^b   Prevo, Remko ^b   Janes, Lauren ^a   Velasco, Paula ^a   Riccardi, Lucia ^a   Alitalo, Kari ^c   Claffey, Kevin ^d   Detmar, Michael ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b JOHN RADCLIFFE HOSPITAL   (United Kingdom)

^c UNIVERSITY OF HELSINKI   (Finland)

^d UNIVERSITY OF CONNECTICUT HEALTH CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

UNCLASSIFIED DRUG; VASCULOTROPIN; VASCULOTROPIN C;

ANGIOGENESIS; ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BREAST CANCER; BREAST METASTASIS; CANCER GROWTH; CONTROLLED STUDY; GENE OVEREXPRESSION; GROWTH STIMULATION; IMMUNOPATHOGENESIS; LUNG METASTASIS; LYMPH NODE METASTASIS; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION;

ANIMALS; BREAST NEOPLASMS; ENDOTHELIAL GROWTH FACTORS; FEMALE; HUMANS; LUNG NEOPLASMS; LYMPH NODES; LYMPHATIC METASTASIS; MICE; MICE, NUDE; NEOPLASM METASTASIS; NEOVASCULARIZATION, PATHOLOGIC; TUMOR CELLS, CULTURED; VASCULAR ENDOTHELIAL GROWTH FACTOR C;

ANIMALIA; MUS MUSCULUS;

EID: 0035122537     PISSN: 10788956     EISSN: None     Source Type: Journal    
DOI: 10.1038/84643     Document Type: Article

References (44)

1. Lymph vessels in rabbit carcinoma, with a note on the normal lymph vessel structure of the testis
2. Surgical management of advanced cancer of the breast
3. Experimental studies on the spread of cancer in the lymphatic system. II. Absence of a lymphatic supply in carcinomas
4. Experimental study on lymphatic vascular changes in the development of cancer
5. Angiogenesis and tumor growth
6. Absence of functional lymphatics within a murine sarcoma: A molecular and functional evaluation
7. VEGF and VEGF-C: Specific induction of angiogenesis and lymphangiogenesis in the differentiated avian chorioallantoic membrane
8. Hyperplasia of lymphatic vessels in VEGF-C transgenic mice
9. Expression of the fms-like tyrosine kinase 4 gene becomes restricted to lymphatic endothelium during development
10. Lymphatic endothelium and Kaposi's sarcoma spindle cells detected by antibodies against the vascular endothelial growth factor receptor-3
11. A novel vascular endothelial growth factor, VEGF-C, is a ligand for the Flt4 (VEGFR-3) and KDR (VEGFR-2) receptor tyrosine kinases
12. Vascular endothelial growth factor (VEGF) and its receptors
13. Vascular endothelial growth factor D (VEGF-D) is a ligand for the tyrosine kinases VEGF receptor 2 (Flk1) and VEGF receptor 3 (Flt4)
14. Expression of vascular endothelial growth factor (VEGF) family members in breast cancer
15. Vascular endothelial growth factors VEGF-B and VEGF-C are expressed in human tumors
16. VEGF, VEGF-B, VEGF-C and their receptors KDR, FLT-1 and FLT-4 during the neoplastic progression of human colonic mucosa
17. Vascular endothelial growth factor-C (VEGF-C) expression in human colorectal cancer tissues
18. Expression of vascular endothelial growth factors A, B, C, and D and their relationships to lymph node status in lung adenocarcinoma
19. Increased vascular endothelial growth factor and vascular endothelial growth factor-c and decreased nm23 expression associated with microdissemination in the lymph nodes in stage I non-small cell lung cancer
20. VEGF-C and VEGFR3 expression in human thyroid pathologies
21. Expression of angiogenesis stimulators and inhibitors in human thyroid tumors and correlation with clinical pathological features
22. Vascular endothelial growth factor-C gene expression in papillary and follicular thyroid carcinomas
23. Role of vascular endothelial growth factor C expression in the development of lymph node metastasis in gastric cancer
24. VEGF and VEGF type C play an important role in angiogenesis and lymphangiogenesis in human malignant mesothelioma tumours
25. High-level expression of angiogenic factors is associated with advanced tumor stage in human neuroblastomas
26. Vascular endothelial growth factor-C expression in human prostatic carcinoma and its relationship to lymph node metastasis
27. Tumorigenicity and metastasis of human breast carcinoma cell lines in nude mice
28. Orthotopic transplant mouse models with green fluorescent protein-expressing cancer cells to visualize metastasis and angiogenesis
29. Proteolytic processing regulates receptor specificity and activity of VEGF-C
30. LYVE-1, a new homologue of the CD44 glycoprotein, is a lymph-specific receptor for hyaluronan
31. Role of the lymphatic system in dissemination of tumor
32. Structure, function and molecular control of the skin lymphatic system
33. On the occurence of newly-formed lymphatic vessels in malignant growths
34. The regeneration of the lymphatics
35. Lymphangiogenesis: Mechanisms, significance and clinical implications
36. Angiogenesis in cancer and other diseases
37. Electron microscopic observations on lymphatic capillaries and the structural components of the connective tissue-lymph interface
38. Some observations on the structure and functions of lymphatics: Their behavior in local edema
39. Transport of molecules in the tumor interstitium: A review
40. Transport of fluid and macromolecules in tumors. II. Role of heterogeneous perfusion and lymphatics
41. Vascular and interstitial barriers to delivery of therapeutic agents in tumors
42. Expression of vascular endothelial growth factor induces an invasive phenotype in human squamous cell carcinomas
43. Halting angiogenesis suppresses carcinoma cell invasion
44. Genes expressed in human tumor endothelium